Kolexia
Lartigau Eric
Radio-thérapie
Centre Oscar-Lambret
Lille, France
285 Activités
320 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Carcinomes Tumeurs de la tête et du cou Récidive tumorale locale Tumeurs du sein Tumeurs du poumon Métastase tumorale Tumeurs du col de l'utérus Carcinome épidermoïde

Industries

AstraZeneca
1 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Clinical research for global needs of radiation oncology.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   28 décembre 2023
Stereotactic reirradiation in the treatment of head and neck cancers: A retrospective study on the long-term experience of the Oscar Lambret Center.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   23 novembre 2023
Unicancer International - Pr Eric LARTIGAU, Directeur Général du Centre Oscar Lambret
Youtube @ UNICANCER - Fédération des Centres de Lutte Contre le Cancer   20 novembre 2023
STEREO-RE-PRO: Phase I/II Multi-center Study Evaluating the Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence After External Radiation Therapy
Essai Clinique (Unicancer)   06 novembre 2023
Early Results of the French Multicenter, Randomized SHARE Trial Comparing Whole Breast Irradiation vs. Accelerated Partial Breast Irradiation in Postmenopausal Women with Early-Stage Breast Cancer
ASTRO 2023: 65th Annual Meeting   01 octobre 2023
IMRT in the treatment of locally advanced or inoperable NSCLC in the pre-durvalumab era: clinical outcomes and pattern of relapses, experience from the Oscar Lambret Center.
Frontiers in oncology   20 septembre 2023
Influence of the Hypersensitivity to Low Dose Phenomenon on the Tumor Response to Hypofractionated Stereotactic Body Radiation Therapy.
Cancers   05 août 2023
Stereotactic body radiation therapy for primary kidney cancer.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   03 août 2023
Five-fraction radiotherapy for breast cancer.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   01 août 2023
Economic evaluation and budget-impact of accelerated partial breast irradiation (APBI) versus standard or hypofractionated whole breast irradiation (WBI) in postmenopausal women with early-stage breast cancer. Results from the French SHARE randomized trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   20 juillet 2023